Skip to main content

Regeneron R3767-ONC

Clinical Trial Grant
Duke Scholars

Administered By

Duke Cancer Institute

Awarded By

Regeneron Pharmaceuticals, Inc.

Start Date

February 1, 2023

End Date

November 17, 2027
 

Administered By

Duke Cancer Institute

Awarded By

Regeneron Pharmaceuticals, Inc.

Start Date

February 1, 2023

End Date

November 17, 2027